Author :   Artemenko M.V.

Cost minimization analysis of neoadjuvant treatment of luminal B HER2/neu-negative breast cancer: chemotherapy versus hormone therapy
Authors: Artemenko M.V. Bondarenko I.M. Zavizion V.F. Avierin D.I. Т. 14, №4 (56)
Neoadjuvant endocrine therapy of breast cancer: history and modern views of the problem
Authors: Zavizion V.F. Artemenko M.V. Т. 14, №3 (55)